It demonstrated that average ALT after interferon therapy ≥ 40 IU/l, IL28B TG/GG, PNPLA3 CG/GG, and steatosis grade ≥ 1 were risk factors associated with rapid fibrosis progression. This evidence concerns the gene PNPLA3 and steatosis.